BioNTech says it will start cancer vaccine trials in the UK from September
Publishing timestamp: 2023-01-06 13:27:43
Summary
The UK government has announced a partnership with German firm BioNTech to test potential vaccines for cancer and other diseases. BioNTech will set up new research and development centers in the UK and aim to deliver 10,000 therapies to patients from September 2023 until the end of the decade. Campaigners have warned that any breakthrough must remain affordable and accessible. The UK government has confirmed that the announcement represents private investment into the UK, but will be supported by a new Cancer Vaccine Launch Pad funded by the NHS.
Sentiment: POSITIVE
Tickers: PFE, MRK, BNTX, MRNA,
Keywords: moderna inc, biotech and pharmaceuticals, pfizer inc, merck & co inc, biontech se, business news, health care industry,